Ischemia-induced interleukin-8 release after human heart transplantation

A potential role for endothelial cells

M. C. Oz, H. Liao, Y. Naka, A. Seldomridge, D. N. Becker, Robert E. Michler, C. R. Smith, E. A. Rose, D. M. Stern, D. J. Pinsky

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Background: Interleukin-8 (IL-8) secreted from endothelial cells is a powerful neutrophil chemoattractant and activator. We hypothesized that human endothelial cells deprived of oxygen would secrete IL-8, which might translate into elevated IL-8 production after cardiac ischemia. Furthermore, we hypothesized that coronary sinus (CS) IL-8 levels would be particularly high after cardiac preservation for transplantation, due to extended ischemic times. Methods and Results: Human saphenous vein endothelial cells exposed to a hypoxic environment (PO2 <20 mm Hg) demonstrated a time-dependent release of IL-8 (measured by ELISA) into the culture supernatant as early as 4 hours alter exposure. To determine whether cardiac preservation in humans was associated with IL-8 production, we obtained CS blood samples 5 minutes after reperfusion in a consecutive series of patients after they underwent cardiac transplantation (CTX, n=20) or elective cardiac surgery (non-CTX, n=21). CTX patients demonstrated significantly higher CS IL-8 levels than non-CTX patients (325±123 versus 50±17 ng/mL, respectively, P<.05). Further analysis of the CS samples revealed that a biochemical marker of myocyte injury (myoglobin) was similarly elevated in the CTX patients compared with the non-CTX patients (3340±625 versus 1151±525 ng/mL, respectively, P<.05). Conclusions: These differences may reflect the longer ischemic times of CTX compared with non-CTX hearts (161±10 versus 80±6 minutes, P<.0001) and suggest that the neutrophil chemoattractant/activator IL-8 may contribute to myocyte injury after prolonged hypothermic cardiac ischemia, as occurs during human cardiac transplantation.

Original languageEnglish (US)
JournalCirculation
Volume92
Issue number9 SUPPL.
StatePublished - 1995
Externally publishedYes

Fingerprint

Heart Transplantation
Interleukin-8
Ischemia
Endothelial Cells
Coronary Sinus
Chemotactic Factors
Muscle Cells
Neutrophils
Myoglobin
Saphenous Vein
Wounds and Injuries
Thoracic Surgery
Reperfusion
Biomarkers
Enzyme-Linked Immunosorbent Assay
Oxygen

Keywords

  • endothelium
  • interleukins
  • ischemia
  • transplantation

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Oz, M. C., Liao, H., Naka, Y., Seldomridge, A., Becker, D. N., Michler, R. E., ... Pinsky, D. J. (1995). Ischemia-induced interleukin-8 release after human heart transplantation: A potential role for endothelial cells. Circulation, 92(9 SUPPL.).

Ischemia-induced interleukin-8 release after human heart transplantation : A potential role for endothelial cells. / Oz, M. C.; Liao, H.; Naka, Y.; Seldomridge, A.; Becker, D. N.; Michler, Robert E.; Smith, C. R.; Rose, E. A.; Stern, D. M.; Pinsky, D. J.

In: Circulation, Vol. 92, No. 9 SUPPL., 1995.

Research output: Contribution to journalArticle

Oz, MC, Liao, H, Naka, Y, Seldomridge, A, Becker, DN, Michler, RE, Smith, CR, Rose, EA, Stern, DM & Pinsky, DJ 1995, 'Ischemia-induced interleukin-8 release after human heart transplantation: A potential role for endothelial cells', Circulation, vol. 92, no. 9 SUPPL..
Oz, M. C. ; Liao, H. ; Naka, Y. ; Seldomridge, A. ; Becker, D. N. ; Michler, Robert E. ; Smith, C. R. ; Rose, E. A. ; Stern, D. M. ; Pinsky, D. J. / Ischemia-induced interleukin-8 release after human heart transplantation : A potential role for endothelial cells. In: Circulation. 1995 ; Vol. 92, No. 9 SUPPL.
@article{894002484077440e83804bfe6026dd67,
title = "Ischemia-induced interleukin-8 release after human heart transplantation: A potential role for endothelial cells",
abstract = "Background: Interleukin-8 (IL-8) secreted from endothelial cells is a powerful neutrophil chemoattractant and activator. We hypothesized that human endothelial cells deprived of oxygen would secrete IL-8, which might translate into elevated IL-8 production after cardiac ischemia. Furthermore, we hypothesized that coronary sinus (CS) IL-8 levels would be particularly high after cardiac preservation for transplantation, due to extended ischemic times. Methods and Results: Human saphenous vein endothelial cells exposed to a hypoxic environment (PO2 <20 mm Hg) demonstrated a time-dependent release of IL-8 (measured by ELISA) into the culture supernatant as early as 4 hours alter exposure. To determine whether cardiac preservation in humans was associated with IL-8 production, we obtained CS blood samples 5 minutes after reperfusion in a consecutive series of patients after they underwent cardiac transplantation (CTX, n=20) or elective cardiac surgery (non-CTX, n=21). CTX patients demonstrated significantly higher CS IL-8 levels than non-CTX patients (325±123 versus 50±17 ng/mL, respectively, P<.05). Further analysis of the CS samples revealed that a biochemical marker of myocyte injury (myoglobin) was similarly elevated in the CTX patients compared with the non-CTX patients (3340±625 versus 1151±525 ng/mL, respectively, P<.05). Conclusions: These differences may reflect the longer ischemic times of CTX compared with non-CTX hearts (161±10 versus 80±6 minutes, P<.0001) and suggest that the neutrophil chemoattractant/activator IL-8 may contribute to myocyte injury after prolonged hypothermic cardiac ischemia, as occurs during human cardiac transplantation.",
keywords = "endothelium, interleukins, ischemia, transplantation",
author = "Oz, {M. C.} and H. Liao and Y. Naka and A. Seldomridge and Becker, {D. N.} and Michler, {Robert E.} and Smith, {C. R.} and Rose, {E. A.} and Stern, {D. M.} and Pinsky, {D. J.}",
year = "1995",
language = "English (US)",
volume = "92",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "9 SUPPL.",

}

TY - JOUR

T1 - Ischemia-induced interleukin-8 release after human heart transplantation

T2 - A potential role for endothelial cells

AU - Oz, M. C.

AU - Liao, H.

AU - Naka, Y.

AU - Seldomridge, A.

AU - Becker, D. N.

AU - Michler, Robert E.

AU - Smith, C. R.

AU - Rose, E. A.

AU - Stern, D. M.

AU - Pinsky, D. J.

PY - 1995

Y1 - 1995

N2 - Background: Interleukin-8 (IL-8) secreted from endothelial cells is a powerful neutrophil chemoattractant and activator. We hypothesized that human endothelial cells deprived of oxygen would secrete IL-8, which might translate into elevated IL-8 production after cardiac ischemia. Furthermore, we hypothesized that coronary sinus (CS) IL-8 levels would be particularly high after cardiac preservation for transplantation, due to extended ischemic times. Methods and Results: Human saphenous vein endothelial cells exposed to a hypoxic environment (PO2 <20 mm Hg) demonstrated a time-dependent release of IL-8 (measured by ELISA) into the culture supernatant as early as 4 hours alter exposure. To determine whether cardiac preservation in humans was associated with IL-8 production, we obtained CS blood samples 5 minutes after reperfusion in a consecutive series of patients after they underwent cardiac transplantation (CTX, n=20) or elective cardiac surgery (non-CTX, n=21). CTX patients demonstrated significantly higher CS IL-8 levels than non-CTX patients (325±123 versus 50±17 ng/mL, respectively, P<.05). Further analysis of the CS samples revealed that a biochemical marker of myocyte injury (myoglobin) was similarly elevated in the CTX patients compared with the non-CTX patients (3340±625 versus 1151±525 ng/mL, respectively, P<.05). Conclusions: These differences may reflect the longer ischemic times of CTX compared with non-CTX hearts (161±10 versus 80±6 minutes, P<.0001) and suggest that the neutrophil chemoattractant/activator IL-8 may contribute to myocyte injury after prolonged hypothermic cardiac ischemia, as occurs during human cardiac transplantation.

AB - Background: Interleukin-8 (IL-8) secreted from endothelial cells is a powerful neutrophil chemoattractant and activator. We hypothesized that human endothelial cells deprived of oxygen would secrete IL-8, which might translate into elevated IL-8 production after cardiac ischemia. Furthermore, we hypothesized that coronary sinus (CS) IL-8 levels would be particularly high after cardiac preservation for transplantation, due to extended ischemic times. Methods and Results: Human saphenous vein endothelial cells exposed to a hypoxic environment (PO2 <20 mm Hg) demonstrated a time-dependent release of IL-8 (measured by ELISA) into the culture supernatant as early as 4 hours alter exposure. To determine whether cardiac preservation in humans was associated with IL-8 production, we obtained CS blood samples 5 minutes after reperfusion in a consecutive series of patients after they underwent cardiac transplantation (CTX, n=20) or elective cardiac surgery (non-CTX, n=21). CTX patients demonstrated significantly higher CS IL-8 levels than non-CTX patients (325±123 versus 50±17 ng/mL, respectively, P<.05). Further analysis of the CS samples revealed that a biochemical marker of myocyte injury (myoglobin) was similarly elevated in the CTX patients compared with the non-CTX patients (3340±625 versus 1151±525 ng/mL, respectively, P<.05). Conclusions: These differences may reflect the longer ischemic times of CTX compared with non-CTX hearts (161±10 versus 80±6 minutes, P<.0001) and suggest that the neutrophil chemoattractant/activator IL-8 may contribute to myocyte injury after prolonged hypothermic cardiac ischemia, as occurs during human cardiac transplantation.

KW - endothelium

KW - interleukins

KW - ischemia

KW - transplantation

UR - http://www.scopus.com/inward/record.url?scp=0343894289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0343894289&partnerID=8YFLogxK

M3 - Article

VL - 92

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 9 SUPPL.

ER -